Cointime

Octarine Bio

company

About

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

  • Copenhagen,Hovedstaden,Denmark
  • 1 - 10

Highlights

Total Funding Amount
€2M $3M
Funding Rounds
5
Investors
6
Employee Profiles
2

Details

Last Funding Type
Seed
Last Funding Money Raised
€2M
Industries
Bioinformatics,Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
€2M $3M
Octarine Bio has raised a total of €2M $3M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2022 Seed €2M 2 DSM Venturing
Oskare Capital 		— Detail
Mar 11, 2021 Seed $1.20M 2 Oskare Capital
Vaekstfonden 		— Detail
Nov 12, 2020 Seed $1.80M 4 Vaekstfonden — Detail
Oct 21, 2020 Non-Equity Assistant — 1 MassChallenge — Detail
Jan 13, 2020 Pre-seed — 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
6
6
Octarine Bio is funded by 6 investors. DSM Venturing and Oskare Capital are the most recent investors.
Investor Name Lead Investor Funding Round
DSM Venturing Yes Seed
Oskare Capital Yes Seed
Vaekstfonden Yes Seed
MassChallenge Yes Non-Equity Assistant
Bruce Linton — Seed
Enexis AB — Seed

Employee Profiles

Number of Employee Profiles
2
Octarine Bio has 2 current employee profiles, including Executive Nick Milne
Nick Milne
Executive
Nethaji Gallage
Executive
Cointime
Chủ Đề
Công Ty